- 2025/12/15 OBP-301, a New Drug Under Development, hasbeen Submitted to Japan’s PMDA for New DrugApplication
- 2025/12/14 OBP-301, the New Drug under Development,Obtained Orphan Drug Designation Approval fromJapan MHLW
- 2025/12/09 Announcement of Important Resolution by the Boardof Directors of Subsidiary Medic Vision AI Limited
- 2025/11/25 The Progress Update of the New Drug underDevelopment, OBP-301
- 2025/11/21 OBP-301, the New Drug under Development,Receives Preliminary Orphan Drug DesignationApproval from Japan MHLW
- 2025/11/10 Announcement of board meeting approved the consolidated financial statements 2025Q3
- 2025/10/31 Announcement of the date of the board of directors meeting for the third quarter of 2025 financial report
- 2025/10/14 The Final Result of Phase II Clinical Trial of OBP-301 Presented in ESMO Congress 2025
- 2025/08/13 Announcement on Behalf of the Subsidiary, TBG Diagnostics Ltd of the Resolutions of the Shareholders' Meeting
- 2025/08/13 Announcement on Election Results of Directors for Subsidiary TBG Diagnostics Ltd.